Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV002315301 | SCV000849048 | uncertain significance | Inborn genetic diseases | 2017-02-15 | criteria provided, single submitter | clinical testing | The p.S34L variant (also known as c.101C>T), located in coding exon 1 of the NDP gene, results from a C to T substitution at nucleotide position 101. The serine at codon 34 is replaced by leucine, an amino acid with dissimilar properties. This amino acid position is not well conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |
Gene |
RCV000828445 | SCV000970134 | likely benign | not provided | 2018-05-30 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000828445 | SCV001025793 | benign | not provided | 2022-08-31 | criteria provided, single submitter | clinical testing |